Humana (HUM) Short-term Investments (2009 - 2026)

Humana (HUM) has reported Short-term Investments for 18 consecutive years, with $17.0 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Short-term Investments fell 3.91% year-over-year to $17.0 billion in Q2 2026; TTM through Jun 2026 was $17.0 billion, a 3.91% decrease from a year earlier, with the FY2025 full-year figure at $15.7 billion, down 13.79% from the prior year.
• Short-term Investments was $17.0 billion for Q2 2026 at Humana, roughly flat from $17.0 billion in the prior quarter.
• Over five years, Short-term Investments peaked at $19.0 billion in Q3 2024 and troughed at $13.0 billion in Q2 2022.
• A 5-year average of $16.0 billion and a median of $16.7 billion in 2023 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments gained 25.67% in 2024 and decreased 13.79% in 2025, its largest moves.
• Over 5 years, Short-term Investments stood at $13.9 billion in 2022, then advanced by 19.78% to $16.6 billion in 2023, then increased by 9.55% to $18.2 billion in 2024, then declined by 13.79% to $15.7 billion in 2025, then grew by 8.12% to $17.0 billion in 2026.
• The last three Short-term Investments figures came in at $17.0 billion (Q2 2026), $17.0 billion (Q1 2026), and $15.7 billion (Q4 2025), per Business Quant data.